drugset / Trial / NCT02172326

Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)

NCT02172326

Phase 3 Completed 29 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

Study to evaluate the pharmacokinetics of tiotropium following 14 days of administration (18µg once per day) in elderly COPD patients.

Timeline

Start
1998-02
Primary completion
1998-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 18 ug Inhaled